EP Patent

EP2768484A1 — Lyophilized liposomes

Assigned to Jazz Pharmaceuticals Research LLC · Expires 2014-08-27 · 12y expired

What this patent protects

Lyophilized liposomal formulations with two or more encapsulated drugs are disclosed. These formulations display superior drug retention profiles and also maintain size distribution following lyophilization and reconstitution.

USPTO Abstract

Lyophilized liposomal formulations with two or more encapsulated drugs are disclosed. These formulations display superior drug retention profiles and also maintain size distribution following lyophilization and reconstitution.

Drugs covered by this patent

Cytarabine (Cytarabine) · Nippon Shinyaku Co., Ltd.

Patent Metadata

Patent number: EP2768484A1
Jurisdiction: EP
Classification: —
Expires: 2014-08-27
Drug substance claim: No
Drug product claim: No
Assignee: Jazz Pharmaceuticals Research LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.